No Data
Top Premarket Gainers
Guggenheim Upgrades Guardant Health to Buy From Neutral, Price Target at $36
Express News | Guardant Health Shares up 3.1% Premarket After Guggenheim Raises to Buy From Neutral
Guggenheim Initiates Guardant Health(GH.US) With Buy Rating, Announces Target Price $36
Guggenheim analyst Subbu Nambi initiates coverage on $Guardant Health(GH.US)$ with a buy rating, and sets the target price at $36.According to TipRanks data, the analyst has a success rate of 50.0% an
Express News | Guardant Health Inc : Guggenheim Raises to Buy From Neutral
American Cancer Society Projects Over 2 Million New Cases in 2024: Biotech Innovations Respond